Thomas Michael Henderson Net Worth & Insider Trades

Thomas Michael Henderson - Chief Business Officer, Bridgebio Pharma, Inc

As of December 17, 2020

What is Thomas Michael Henderson's Net Worth?

The current estimated net worth of Bridgebio Pharma, Inc's Chief Business Officer, Thomas Michael Henderson, is estimated to be about $5.8M . Thomas Michael Henderson owns about 274,211 units of Bridgebio Pharma, Inc common stock. In the last year at Bridgebio Pharma, Inc, Thomas Michael Henderson has sold an estimated value of $4.19M worth.

What is Thomas Michael Henderson's Past Insider Trading?

Thomas Michael Henderson's largest purchase order was 180,767 units , worth over $119K on July 3, 2019. Thomas Michael Henderson's largest sale order was 16,353 units , worth over $731.63K on November 18, 2020. In total, Thomas Michael Henderson has made about 22 transactions over a year of their time at Bridgebio Pharma, Inc. Thomas Michael Henderson usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 10,000 units , worth over $515.2K on December 2, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Thomas Michael Henderson's Salary in 2020?

As Chief Business Officer of Bridgebio Pharma, Inc, Thomas Michael Henderson has a total base salary of $515,000 . Thomas Michael Henderson received compensation valued at about $7,991,241 in 2020 after becoming Chief Business Officer. The vast majority of their compensation came in the form of a bonus of $300,000 , stock awards of $7,072,500 , option awards of $91,899 , and other compensation of $11,843 .

What is Thomas Michael Henderson's' Mailing Address?

  • Mailing address is 421 Kipling Street Palo Alto CA 94301 CA

Bridgebio Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

What are Bridgebio Pharma, Inc's Past Insider Trades?

Bridgebio Pharma, Inc's most recent insider trade came on March 17, 2022 by Andrea Ellis who bought 12,000 units worth $100.68K . In the last 3 years, insiders at Bridgebio Pharma, Inc have sold an estimated value of $352.17M and bought an estimated value of $213.34M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Neil Kumar, CEO and President,  Brian C Stephenson, Secretary,  and Thomas Michael Henderson, Chief Business Officer .

BridgeBio Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1